Consistent with the results of studies investigating ectopic expression models of TRPC3/C6, cardiomyocyte-specific overexpression of a dominant-negative TRPC3/C6 mutants suppressed both neurohumoral-factor-induced and pressure-overload-induced cardiac hypertrophy and dysfunction [36]. This evidence concerns the gene TRPC3 and cardiac hypertrophy.